CommentaryEuropean Policy

Translational Medicine Policy Issues in Infectious Disease

Science Translational Medicine  13 Jan 2010:
Vol. 2, Issue 14, pp. 14cm2
DOI: 10.1126/scitranslmed.3000375

You are currently viewing the abstract.

View Full Text


The European Academies Science Advisory Council has published a series of reports on infectious disease policy issues, analyzing priorities for building the science base as part of public health strategy. Among current challenges facing the European Union are the needs to tackle antibiotic resistance, promote vaccine innovation, prepare for the emergence of novel zoonoses, and integrate research approaches to human and animal health. The scientific community must help public policy-makers to address the organization, balance, and sustainability of research funding and infrastructure; encourage the creation of a more supportive regulatory environment for translational medicine; and evaluate new models for public-private partnership to facilitate innovation.


  • Citation: R. Fears, J. W. M. van der Meer, V. ter Meulen, Translational medicine policy issues in infectious disease. Sci. Transl. Med. 2, 14cm2 (2010).

View Full Text